J. Musard, M. Sallot, P. Dulieu, A. Fraichard, C. Ordener et al., Identification and Expression of a New Sulfhydryl Oxidase SOx-3 during the Cell Cycle and the Estrus Cycle in Uterine Cells, Biochemical and Biophysical Research Communications, vol.287, issue.1, pp.83-91, 2001.
DOI : 10.1006/bbrc.2001.5440

D. Coppock, D. Cina-poppe, and S. Gilleran, The Quiescin Q6 Gene (QSCN6) Is a Fusion of Two Ancient Gene Families: Thioredoxin and ERV1, Genomics, vol.54, issue.3, pp.460-468, 1998.
DOI : 10.1006/geno.1998.5605

D. Coppock, C. Kopman, J. Gudas, and D. Cina-poppe, Regulation of the Quiescence-Induced Genes: Quiescin Q6, Decorin, and Ribosomal Protein S29, Biochemical and Biophysical Research Communications, vol.269, issue.2, pp.604-610, 2000.
DOI : 10.1006/bbrc.2000.2324

B. Benayoun, A. Esnard-fève, S. Castella, Y. Courty, and F. Esnard, Rat seminal vesicle FAD-dependent sulfhydryl oxidase. Biochemical characterization and molecular cloning of a member of the new sulfhydryl oxidase/ quiescin Q6 gene family, J Biol Chem, vol.276, pp.13830-13837, 2001.

A. Tury, G. Mairet-coello, F. Poncet, C. Jacquemard, P. Risold et al., QSOX sulfhydryl oxidase in rat adenohypophysis: localization and regulation by estrogens, Journal of Endocrinology, vol.183, issue.2, pp.353-363, 2004.
DOI : 10.1677/joe.1.05842

D. Coppock and C. Thorpe, Multidomain Flavin-Dependent Sulfhydryl Oxidases, Antioxidants & Redox Signaling, vol.8, issue.3-4, pp.300-311, 2006.
DOI : 10.1089/ars.2006.8.300

K. Hoober, B. Joneja, H. White, and C. Thorpe, A Sulfhydryl Oxidase from Chicken Egg White, Journal of Biological Chemistry, vol.271, issue.48, pp.30510-30516, 1996.
DOI : 10.1074/jbc.271.48.30510

C. Thorpe, K. Hoober, S. Raje, N. Glynn, J. Burnside et al., Sulfhydryl oxidases: emerging catalysts of protein disulfide bond formation in eukaryotes, Archives of Biochemistry and Biophysics, vol.405, issue.1, pp.1-12, 2002.
DOI : 10.1016/S0003-9861(02)00337-5

K. Hoober, S. Sheasley, H. Gilbert, and C. Thorpe, Sulfhydryl Oxidase from Egg White: A FACILE CATALYST FOR DISULFIDE BOND FORMATION IN PROTEINS AND PEPTIDES, Journal of Biological Chemistry, vol.274, issue.32, pp.22147-150, 1999.
DOI : 10.1074/jbc.274.32.22147

C. Thorpe and D. Coppock, Generating Disulfides in Multicellular Organisms: Emerging Roles for a New Flavoprotein Family, Journal of Biological Chemistry, vol.282, issue.19, pp.13929-13933, 2007.
DOI : 10.1074/jbc.R600037200

C. Morel, P. Adami, J. Musard, D. Duval, J. Radom et al., Involvement of sulfhydryl oxidase QSOX1 in the protection of cells against oxidative stress-induced apoptosis, Experimental Cell Research, vol.313, issue.19, pp.3971-3982, 2007.
DOI : 10.1016/j.yexcr.2007.09.003
URL : https://hal.archives-ouvertes.fr/hal-00482222

D. Bostwick, E. Alexander, R. Singh, A. Shan, J. Qian et al., Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer, Cancer, vol.90, issue.1, pp.123-134, 2000.
DOI : 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9

T. Oberley, Oxidative Damage and Cancer, The American Journal of Pathology, vol.160, issue.2, pp.403-408, 2002.
DOI : 10.1016/S0002-9440(10)64857-2

D. Coppock, C. Kopman, S. Scandalis, and S. Gilleran, Preferential gene expression in quiescent human lung fibroblasts, Cell Growth Differ, vol.4, pp.483-493, 1993.

K. Antwi, G. Hostetter, M. Demeure, B. Katchman, G. Decker et al., Analysis of the Plasma Peptidome from Pancreas Cancer Patients Connects a Peptide in Plasma to Overexpression of the Parent Protein in Tumors, Journal of Proteome Research, vol.8, issue.10, pp.4722-4731, 2009.
DOI : 10.1021/pr900414f

B. Katchman, K. Antwi, G. Hosteller, M. Demeure, A. Watanabe et al., Quiescin Sulfhydryl Oxidase 1 Promotes Invasion of Pancreatic Tumor Cells Mediated by Matrix Metalloproteinases, Molecular Cancer Research, vol.9, issue.12, pp.1621-1631, 2011.
DOI : 10.1158/1541-7786.MCR-11-0018

H. Song, B. Zhang, M. Watson, P. Humphrey, H. Lim et al., Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis, Oncogene, vol.162, issue.37, pp.3307-3319, 2009.
DOI : 10.1158/0008-5472.CAN-05-1550

D. Hellebrekers, V. Melotte, E. Vire, E. Langenkamp, G. Molema et al., Identification of Epigenetically Silenced Genes in Tumor Endothelial Cells, Cancer Research, vol.67, issue.9, pp.4138-4148, 2007.
DOI : 10.1158/0008-5472.CAN-06-3032

A. Berthier, S. Seguin, A. Sasco, J. Bobin, D. Laroche et al., High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer, British Journal of Cancer, vol.65, issue.6, pp.1024-1031, 2010.
DOI : 10.1073/pnas.76.9.4350
URL : https://hal.archives-ouvertes.fr/hal-00468457

E. O. Second and . Workshop, EORTC: Revision of the standards for the assessment of hormone receptors in human breast cancer, The Netherlands Cancer Institute, pp.16-171513, 1979.

F. Descotes, B. Riche, S. Saez, D. Laroche, G. Datchary et al., Plasminogen Activator Inhibitor Type 1 is the Most Significant of the Usual Tissue Prognostic Factors in Node-Negative Breast Ductal Adenocarcinoma Independent of Urokinase-Type Plasminogen Activator, Clinical Breast Cancer, vol.8, issue.2, pp.168-177, 2008.
DOI : 10.3816/CBC.2008.n.018
URL : https://hal.archives-ouvertes.fr/hal-00428276

A. Berton, V. Rigot, E. Huet, M. Decarme, Y. Eeckhout et al., Involvement of Fibronectin Type II Repeats in the Efficient Inhibition of Gelatinases A and B by Long-chain Unsaturated Fatty Acids, Journal of Biological Chemistry, vol.276, issue.23, pp.20458-20465, 2001.
DOI : 10.1074/jbc.M011664200

M. Simian, Y. Hirai, M. Navre, Z. Werb, A. Lochter et al., The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells, Development, vol.128, pp.3117-3131, 2001.

A. Hamburger, The Human Tumor Clonogenic Assay as a Model System in Cell Biology, The International Journal of Cell Cloning, vol.48, issue.2, pp.89-107, 1987.
DOI : 10.1002/stem.5530050202

N. Colburn, W. Bruegge, J. Bates, R. Gray, J. Rossen et al., Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells, Cancer Res, vol.38, pp.624-634, 1978.

I. Fidler, Understanding bone metastases: the key to the effective treatment of prostate cancer, Clin Adv Hematol Oncol, vol.1, pp.278-279, 2003.

N. Simon, A. Noel, and J. Foidart, Evaluation of in vitro reconstituted basement membrane assay to assess the invasiveness of tumor cells, Invasion Metastasis, vol.12, pp.156-167, 1992.

E. Deryugina, G. Luo, R. Reisfeld, and M. Bourdon, Strongin A: Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2, Anticancer Res, vol.17, pp.3201-3210, 1997.

C. Nemos, R. Delage-mourroux, M. Jouvenot, and P. Adami, Onset of direct 17-?? estradiol effects on proliferation and c-fos expression during oncogenesis of endometrial glandular epithelial cells, Experimental Cell Research, vol.296, issue.2, pp.109-122, 2004.
DOI : 10.1016/j.yexcr.2004.01.028

R. Neve, K. Chin, J. Fridlyand, J. Yeh, F. Baehner et al., A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes, Cancer Cell, vol.10, issue.6, pp.515-527, 2006.
DOI : 10.1016/j.ccr.2006.10.008

N. Franken, H. Rodermond, J. Stap, J. Haveman, and C. Van-bree, Clonogenic assay of cells in vitro, Nature Protocols, vol.19, issue.5, pp.2315-2319, 2006.
DOI : 10.1080/095530097143653

B. Yan and J. Smith, A Redox Site Involved in Integrin Activation, Journal of Biological Chemistry, vol.275, issue.51, pp.39964-39672, 2000.
DOI : 10.1074/jbc.M007041200

J. Lahav, N. Gofer-dadosh, J. Luboshitz, O. Hess, and M. Shaklai, Protein disulfide isomerase mediates integrin-dependent adhesion, FEBS Letters, vol.91, issue.2, pp.89-92, 2000.
DOI : 10.1016/S0014-5793(00)01630-6

J. Lahav, K. Jurk, O. Hess, M. Barnes, R. Farndale et al., Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange, Blood, vol.100, issue.7, pp.2472-2478, 2002.
DOI : 10.1182/blood-2001-12-0339

M. Durand, J. Bødker, A. Christensen, D. Dupont, M. Hansen et al., Plasminogen activator inhibitor-1 and tumour growth, invasion, and metastasis, Thrombosis and Haemostasis, vol.9, pp.438-449, 2004.
DOI : 10.1160/TH03-12-0784

A. Strimpakos, M. Saif, and K. Syrigos, Pancreatic cancer: from molecular pathogenesis to targeted therapy, Cancer and Metastasis Reviews, vol.121, issue.3, pp.495-522, 2008.
DOI : 10.1007/s10555-008-9134-y

E. Thompson, S. Paik, N. Brünner, C. Sommers, G. Zugmaier et al., Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines, Journal of Cellular Physiology, vol.46, issue.4, pp.534-544, 1992.
DOI : 10.1002/jcp.1041500314

C. Gialeli, A. Theocharis, and N. Karamanos, Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting, FEBS Journal, vol.188, issue.5, pp.16-27, 2011.
DOI : 10.1111/j.1742-4658.2010.07919.x

A. Kandasamy, A. Chow, M. Ali, and R. Schulz, Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix, Cardiovascular Research, vol.85, issue.3, pp.413-423, 2010.
DOI : 10.1093/cvr/cvp268

W. Stetler-stevenson, Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention, Journal of Clinical Investigation, vol.103, issue.9, pp.1237-1241, 1999.
DOI : 10.1172/JCI6870